Chronoscale Holdings Corporation cash flow statement CHRN

Annual Quarterly

In fiscal 2026, which ended May 31, 2026, Chronoscale Holdings Corporation generated $39.1 million of cash from operations, up 431.0% from the year before. It spent $26.9 million on capital expenditures. That left free cash flow of $12.2 million.

USD in millions, except per-share amounts and ratios. The percent under a figure is the change from the year before.

FY 2027
Aug 31, 2026
FY 2026
May 31, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2017
Dec 31, 2017
Operating
Depreciation and amortization
75
+4461.8%
60
+3736.0%
2
-2.2%
2
-5.3%
2
+91.4%
1
-13.3%
1
+65.0%
1
-10.1%
1
-31.6%
1
-15.7%
1
-35.5%
Stock-based compensation
11
+745.4%
1
-12.0%
1
+7.4%
1
-26.1%
2
-27.0%
3
+9.3%
2
-3.4%
2
+6.9%
2
-21.4%
3
+18.8%
2
-22.7%
Operating cash flow
56
+566.7%
39
+431.0%
-12
-19.9%
-10
+18.3%
-12
+17.9%
-15
-31.7%
-11
-27.4%
-9
+44.5%
-16
+28.8%
-22
+29.0%
-31
Investing
Capital expenditures
30
+16719.7%
27
+14195.7%
0
+408.1%
0
-76.4%
0
-19.1%
0
+228.8%
0
0
-100.0%
0
-54.2%
0
-71.3%
0
-58.4%
Investing cash flow
-28
-15760.7%
-25
-13287.8%
-0
-408.1%
-0
+76.4%
-0
+97.0%
-5
-8671.2%
-0
0
+100.0%
-0
+54.2%
-0
+71.3%
-0
+58.4%
Financing
Debt issued
—
—
—
—
—
—
0
-100.0%
3
—
—
0
-100.0%
Financing cash flow
-18
-318.4%
-7
-200.0%
7
-14.7%
8
+2132.5%
0
0
-100.0%
39
+261.7%
11
-43.8%
19
+737.6%
2
-94.7%
43
Change in cash
Effect of exchange rate
—
—
0
+216.1%
-0
-29.2%
-0
-33.3%
-0
-138.3%
0
+14.6%
0
+310.0%
0
—
—
Net change in cash
10
+346.2%
7
+236.5%
-5
-148.2%
-2
+82.0%
-12
+40.2%
-20
-172.2%
28
+1284.1%
2
-38.1%
3
—
—
Free cash flow
26
+313.2%
12
+201.7%
-12
-21.3%
-10
+19.1%
-12
+17.9%
-15
-32.7%
-11
-28.1%
-9
+44.7%
-16
+29.0%
-22
+29.6%
-32
Per share
Free cash flow per share
—
0.09
—
-0.49
+44.3%
-0.88
+23.3%
-1.15
-25.6%
-0.91
+25.2%
-1.22
+63.0%
-3.30
-806.9%
-0.36
+59.1%
-0.89
Ratios
Free cash flow margin
23.32%
17.03%
-93.67%
-55.14%
-66.80%
-115.26%
-99.72%
-98.57%
-113.76%
-196.75%
-430.87%
Capital expenditures to revenue
26.99%
37.53%
1.47%
0.21%
0.86%
1.50%
0.52%
0.00%
0.43%
1.16%
6.20%
Stock-based compensation to revenue
10.20%
1.81%
11.52%
7.66%
10.16%
19.72%
20.71%
27.13%
16.20%
25.31%
32.83%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and ratios. Capital expenditures, debt repaid, dividends, and buybacks are positive amounts. Investing and financing cash flow keep the filing sign, so an outflow is negative. Free cash flow is operating cash flow minus capital expenditures. The first column is the trailing twelve months through the latest quarter. Returned to shareholders is dividends plus buybacks. Free cash flow margin, capital expenditures, and stock-based compensation are divided by revenue. Cash conversion is operating cash flow divided by net income. More on our methodology.

Company profile

Industry
General Industrial Machinery & Equipment, NEC (SIC 3569)
Listed as
CHRN (Nasdaq)
Fiscal year ends
May 31
Headquarters
Menlo Park, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1549084
Former names
ChronoScale Corp (until Jul 1, 2026); EKSO BIONICS HOLDINGS, INC. (until May 5, 2026); PN Med Group Inc (until Dec 31, 2013)

Other General Industrial Machinery & Equipment, NEC companies

All 16 General Industrial Machinery & Equipment, NEC companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.